Patient support during GLP‑1 arGLP‑1 therapy: practical solutions for cosmetologists
https://doi.org/10.33667/2078-5631-2025-23-7-10
Abstract
The strategy of developing personalized protocols of aesthetic intervention for patients with medical weight loss (MWL) is a relevant task for cosmetologists in the current realities, since the number of such patients is rapidly increasing, which causes high demand. This article presents an algorithm for comprehensive aesthetic support for a patient in the process of losing weight.
About the Authors
I. A. Akhmedbaeva
Central State Medical Academy of the Administrative Department of the President of Russian Federation
Russian Federation
Russian Federation
Akhmedbaeva Inga A., PhD Med, associate professor at Dept of Dermatovenereology and Cosmetology
Moscow
L. S. Kruglova
Central State Medical Academy of the Administrative Department of the President of Russian Federation
Russian Federation
Russian Federation
Kruglova Larisa S., DM Sci (habil.), professor, head of Dept of Dermatovenereology and Cosmetology, vice‑rector for Academic Affairs
Moscow
N. V. Gryazeva
Central State Medical Academy of the Administrative Department of the President of Russian Federation
Russian Federation
Russian Federation
Gryazeva Natalya V., DM Sci (habil.), professor at Dept of Dermatovenereology and Cosmetology
Moscow
References
1. World Health Organization, “Obesity and Overweight”, 2024, https://www.who.int/news room/fact sheets/detail/obesity and overweight. [Ref list].
2. Han S.H., Safeek R., Ockerman K., et al., “Public Interest in the off Label Use of Glucagon Like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis,” Aesthetic Surgery Journal 44, no. 1 (2023): 60–67.
3. State Register of Medicines LP No. (010345) (RG RU) dated May 28, 2025).
4. Wilding J.P.H., Batterham R.L., Calanna S., et al. STEP 1 Study Group. Once Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18; 384 (11): 989 1002.
5. Lincoff A.M., Brown Frandsen K., Colhoun H.M., et al. SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14; 389 (24): 2221–2232.
6. State Register of Medicines (minzdrav.gov.ru), Tiretta (tirzepatide) RU: LP No. (008551) (PF RU) dated 23.01.2025.
7. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022; 24: 1553–1564.
8. Torshin I. Yu., Gromova O.A. Problems of using phenol (hydroxybenzene) and parabens as stabilizers of pharmaceuticals: analysis using machine learning methods. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2025; 18 (1): 125–139. (In Russ.). https://doi.org/10.17749/2070–4909/farmakoekonomika.2024.263
9. Yao H., Zhang A., Li D., et al., “Comparative Effectiveness of GLP 1 Receptor Agonists on Glycaemic Control, Body Weight, and Lipid Profile for Type 2 Diabetes: Systematic Review and Network Meta Analysis”, BMJ 384 (2024).
10. Jafar A.B., Jacob J., Kao W.K., et al. Soft Tissue Facial Changes Following Massive Weight Loss Secondary to Medical and Surgical Bariatric Interventions: A Systematic Review”, Aesthetic Surgery Journal Open Forum 6 (2024).
11. Haykal D., Hersant B., Cartier H., et al. The Role of GLP 1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health J Cosmet Dermatol. 2024 Dec 8; 24 (2).
12. Nikolis A., Enright K. M, Fabi S.G. et al. Consensus Statements on Managing Aesthetic Needs in Prescription Medication Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study J Cosmet Dermatol. 2025 Mar 26; 24 (4).
13. Haykal D. and Cartier H., “Unveiling the Psychological and Ethical Journey of Cosmetic Dermatology Procedures,” Journal of the European Academy of Dermatology and Venereology 38 (2023).
14. Haykal D., “Pilot Prospective Study Evaluating the Anti Aging Efficacy, Tolerability, and Improvement of Skin Quality by Hyaluronic Acid Injections for Mid and Lower Face,” Journal of Cosmetic Dermatology 21, no. 10 (2022): 5259–5260.
15. Nguyen L., Blessmann M., Schneider S.W., and Herberger K., “Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region,” Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 48, no. 12 (2022): 1299–1305.
16. Ikonnikova E.V., Kruglova L.S., Kruglova M.S. The effect of glucagon like peptide 1 receptor agonists on facial adipose tissue: myth or reality? Effective Pharmacotherapy. 2025; 21 (12): 56–60. (In Russ.). DOI 10.33978/2307-3586-2025-21-12-56-60
17. Haykal D., Cartier H., Goldberg D., and Gold M., “Advancements in Laser Technologies for Skin Rejuvenation: A Comprehensive Review of Efficacy and Safety”, Journal of Cosmetic Dermatology 23, no. 10 (2024): 3078–3089.
Review
For citations:
Akhmedbaeva I.A., Kruglova L.S., Gryazeva N.V. Patient support during GLP‑1 arGLP‑1 therapy: practical solutions for cosmetologists. Medical alphabet. 2025;1(23):7-10. (In Russ.) https://doi.org/10.33667/2078-5631-2025-23-7-10
Views:
13
Email this article 